Search results for Elanco

Elanco acquires Dutch company AHV

Elanco Animal Health announced it has closed its acquisition of AHV International, a Dutch innovator in farm animal health. The acquisition is said to offer dairy producers an expa...

Stifel reiterates buy on Elanco stock, keeps $32 price target

<![CDATA[Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics ]]>

<![CDATA[Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics]]>

<![CDATA[Eli Lilly Enters $ 2.3 Billion Agreement to Acquire Ajax Therapeutics ]]>

Eli Lilly to Acquire Kelonia Therapeutics

On April 20, 2026, Eli Lilly & Company (“Lilly”) and Kelonia Therapeutics, Inc. (“Kelonia”) announced an agreement for Lilly to acquire Kelonia in an all-cash transaction expec...

Lilly to buy startup Ajax in bid for a better JAK drug

Worth up to $2.3 billion overall, the deal hands Lilly a drug designed to address the weaknesses of a class of medicines used to treat myelofibrosis and other diseases.

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>

<![CDATA[Eli Lilly Enters Three Separate Acquisitions Totaling $3.83 Billion ]]>

Lilly maintains M&A hot streak with $2.3B deal for next-gen JAK inhibitor biotech Ajax

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy.

Lilly snaps up Engage to advance non-viral genetic medicines

The acquisition is Lilly’s latest push into genetic medicine, giving it a technology designed to overcome some of the field’s longstanding limitations.

Ceva Animal Health appoints Sébastien Huron as Deputy Chief Executive Officer

Lilly makes preclinical ADC specialist CrossBridge its latest acquisition in vague $300M deal

Eli Lilly has turned its attention down south with a $300 million biobuck acquisition of Houston-based CrossBridge Bio, aiming to advance its dual-payload antibody-drug conjugate (...

StockWatch: Price War Dampens Lilly Surge After Oral GLP-1 Wins FDA Nod

Trung Huynh, an analyst with RBC Capital Markets, has projected Foundayo will reach peak-year sales of $36 billion—14% above the $31.68 billion racked up by last year’s best sellin...

Lilly dives into vaccine research with 3 biotech buyouts

Worth close to $4 billion combined, the acquisitions of Curevo, LimmaTech and Vaccine Co. signal plans by Lilly to build an infectious disease portfolio.

Eli Lilly’s Vaccine Acquisitions Signal a Strategy of Growth in New Areas

Eli Lilly is spending up to $3.8 billion to buy vaccines in development for shingles, staph infections, and Epstein-Barr virus as well as the platform technologies that spawned the...

FDA and EPA grant emergency use of Elanco screwworm treatments

Negasunt Powder and Tanidil will be available only through APHIS via National Veterinary Stockpile.

Lilly boosts ADC portfolio with CrossBridge Bio deal

Worth up to $300 million, the buyout is Lilly’s latest of an ADC maker and adds technology for making “dual-payload” therapies.

May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion

May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion admin Tue, 05/26/2026 - 11:55 Lilly keeps pushing forward with deals and pipeline mome...

April 27 2026 - Lilly lands third oncology deal in 3 weeks, inking up to $2.3B for Ajax

April 27 2026 - Lilly lands third oncology deal in 3 weeks, inking up to $2.3B for Ajax admin Mon, 04/27/2026 - 11:40 It’s all about the deals today—Lilly keeps spe...

<![CDATA[Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal]]>

Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout

Worth up to $7 billion, Lilly’s second recent acquisition of a company in the space is centered around a cell therapy that’s currently in early-stage testing for multiple myeloma.

Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health

Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool...